8-KOther Events

HCA Healthcare, Inc. 8-K Report (Sep 21, 2000)

Filed September 21, 2000For Securities:HCA

Summary

HCA Healthcare, Inc. (HCA) filed an 8-K report on September 20, 2000, detailing events related to the issuance and sale of $500 million in aggregate principal amount of Floating Rate Senior Notes due September 19, 2002. The filing indicates the company successfully completed this debt offering, which is a significant event for investors as it impacts the company's capital structure and liquidity. The report includes key underwriting agreements and the specific details of the notes being issued, separating them into two tranches of $400 million and $100 million. This offering provides HCA with substantial capital, likely for general corporate purposes or strategic initiatives. Investors should note the floating rate nature of these notes, which means their interest expense will fluctuate with market rates.

Key Highlights

  • 1HCA successfully issued and sold $500 million in aggregate principal amount of Floating Rate Senior Notes.
  • 2The Senior Notes are due to mature on September 19, 2002.
  • 3The debt offering was structured into two parts: a $400 million note and a $100 million note.
  • 4The filing includes the Underwriting Agreement, outlining the terms of the sale with Chase Securities Inc. and J.P. Morgan Securities Inc.
  • 5This issuance provides HCA with significant capital, impacting its balance sheet and financial flexibility.
  • 6The notes carry a floating interest rate, which will adjust with market conditions.

Frequently Asked Questions

The primary purpose of this 8-K filing was to report the completion of HCA Healthcare's issuance and sale of $500 million in Floating Rate Senior Notes due September 19, 2002, and to provide the necessary documentation related to this debt offering.

HCA issued $500 million in aggregate principal amount of Floating Rate Senior Notes, with a maturity date of September 19, 2002. The notes are structured as two separate tranches: one for $400 million and another for $100 million. Crucially, these notes have a floating interest rate, meaning the interest paid will change based on market conditions.

The underwriters for this debt issuance were Chase Securities Inc. and J.P. Morgan Securities Inc., as detailed in the filed Underwriting Agreement.

This issuance increases HCA's total debt and cash balance. The infusion of $500 million provides the company with increased liquidity and capital, which could be used for various corporate purposes such as acquisitions, capital expenditures, or refinancing existing debt. However, it also increases the company's financial leverage and introduces interest rate risk due to the floating rate nature of the notes.